Bayer's mineralocorticoid receptor antagonist (MRA) Kerendia hit the mark as a treatment for a common form of heart failure in the FINEARTS-HF study, setting up regulatory approvals, but there is ...
On the flip side, rising prostate cancer drug Nubeqa and chronic kidney disease med Kerendia should continue on their growth trajectories throughout the year. Bayer has long charted a blockbuster ...
On the heels of approvals in the US, Europe and Japan, Bayer's Kerendia for chronic kidney disease (CKD) associated with type 2 diabetes has been cleared for use in China, unlocking another big ...
Bloomberg on MSN3mon
Bayer Kidney Drug Helps Treat Common Form of Heart Failure(Bloomberg) -- Bayer AG’s kidney drug Kerendia helped patients avoid complications from a common form of heart failure in a ...
The thinking was that the drug could be a possible rival to Bayer’s approved chronic kidney disease (CKD) drug Kerendia. But those ambitions went up in flames in July when a prespecified interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback